---
source: https://www.mckesson.com/about-us/newsroom/press-releases/2024/mckesson-signs-agreement-to-acquire-controlling-interest-in-florida-cancer-specialists--research-institutes-core-ventures/
date: 2024-08-26
type: Company
---

# McKesson Acquires Core Ventures for $2.49B

McKesson signed definitive agreement to acquire 70% controlling interest in Core Ventures for $2.49B cash.

## Transaction Details

- **Price:** $2.49B cash for 70% ownership
- **Seller:** Florida Cancer Specialists & Research Institute (FCS)
- **FCS Retention:** Physicians retain minority interest
- **Announced:** August 26, 2024

## About Core Ventures

- Management services organization for FCS
- Supports ~100 FCS clinics throughout Florida
- Provides operational and advisory services
- Developed in 2024 to partner with distributors amid drug shortages

## About FCS

- 250+ physicians, 280 advanced practice providers
- ~100 locations in Florida
- Will join McKesson's US Oncology Network

## Strategic Rationale

"This milestone marks an important step forward in our efforts to advance community-based oncology care," said McKesson CEO Brian Tyler. Growing oncology platform to bring advanced treatments while reducing overall cost of care.

## Regulatory

FTC did not block the deal - regulatory green light for MSO consolidation.
